Table 1.
Clinicopathological characteristics.
| Characteristics | Number of patients (n = 30) |
|---|---|
| Gender | |
| Male | 11 |
| Female | 19 |
| Age (years) | |
| ≤60 | 21 |
| >60 | 9 |
| Lugano stage | |
| Stage I | 10 |
| Stage II | 9 |
| Stage IV | 11 |
| Number of lesion(s) in GI tract | |
| One | 26 |
| Two or more than two | 4 |
| Involved sites in GI tract | |
| Fundus of stomach | 1 |
| Body of stomach | 14 |
| Antrum of stomach | 11 |
| Duodenum | 4 |
| Jejunum or ileum | 3 |
| Ileocecal junction | 4 |
| Colon | 4 |
| Histological subtype | |
| GCB-DLBCL | 13 |
| Non-GCB-DLBCL | 17 |
| IPI score | |
| 0 | 9 |
| 1 | 9 |
| 2 | 3 |
| 3 | 7 |
| 4 | 2 |
| 5 | 0 |
| Interim response evaluation | |
| CR | 20 |
| Non-CR | 10 |
GI: gastrointestinal; GCB-DLBCL: germinal center B-cell-like diffused large B-cell lymphoma; IPI: international prognostic index; CR: complete remission.